Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.7K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.7K
Stem Cell Culture01:17

Stem Cell Culture

6.3K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Wiskott-Aldrich Syndrome protein (WASp) contribution to microglial phagocytic function and neurodevelopmental support.

Journal of neuroinflammation·2026
Same author

Transport Coherence Loss in Heterogeneous Forward Osmosis Membranes: A Hierarchical Diagnostic Framework.

Membranes·2026
Same author

Harnessing Hydrogel Interaction with Functional Polymeric Nanoparticles for Sustained Co-Delivery of Therapeutics.

ACS biomaterials science & engineering·2026
Same author

Hydrogels for the treatment of spinal cord injury: progress and promise.

Nanomedicine (London, England)·2026
Same author

Modelling the impact of temperature on nanocarrier behavior: Thermodynamics, structural transitions, and drug release.

Advances in colloid and interface science·2026
Same author

Rational design of microfluidic templated HA-LPEI nanogels for the targeted delivery of doxorubicin.

Journal of materials chemistry. B·2026

Related Experiment Video

Updated: Feb 24, 2026

Author Spotlight: Long-Term Spinal Cord Slice Culture for Advancing Spinal Cord Regeneration Therapies
07:37

Author Spotlight: Long-Term Spinal Cord Slice Culture for Advancing Spinal Cord Regeneration Therapies

Published on: April 12, 2024

2.3K

Current Options for Cell Therapy in Spinal Cord Injury.

Irma Vismara1, Simonetta Papa1, Filippo Rossi2

  • 1Dipartimento di Neuroscienze, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto di Ricerche Farmacologiche Mario Negri, via La Masa 19, 20156 Milano, Italy; These authors contributed equally to this work.

Trends in Molecular Medicine
|August 17, 2017
PubMed
Summary

Spinal cord injury (SCI) treatments are advancing with cell therapies and biomaterials. Combinatorial approaches using cells, drugs, and biomaterials show promise for improved sensory and motor function recovery.

More Related Videos

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery
05:13

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery

Published on: June 7, 2024

533
Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
10:49

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury

Published on: September 18, 2011

21.3K

Related Experiment Videos

Last Updated: Feb 24, 2026

Author Spotlight: Long-Term Spinal Cord Slice Culture for Advancing Spinal Cord Regeneration Therapies
07:37

Author Spotlight: Long-Term Spinal Cord Slice Culture for Advancing Spinal Cord Regeneration Therapies

Published on: April 12, 2024

2.3K
Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery
05:13

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery

Published on: June 7, 2024

533
Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
10:49

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury

Published on: September 18, 2011

21.3K

Area of Science:

  • Regenerative Medicine
  • Neuroscience
  • Biomaterials Science

Background:

  • Spinal cord injury (SCI) involves primary mechanical damage and secondary tissue damage, worsening outcomes.
  • Preclinical studies show cell treatments can improve sensory/motor function in SCI.
  • Combinatorial therapies (cell + drug/biological factors) are more effective than cell therapy alone.

Purpose of the Study:

  • To review single and combinatorial regenerative cell treatments for SCI.
  • To explore potential in situ cell delivery options using biomaterials.
  • To highlight multitarget strategies for maximized therapeutic effects in SCI.

Main Methods:

  • Literature review of preclinical and clinical studies on SCI regenerative treatments.
  • Analysis of cell-based therapies, including single and combinatorial approaches.
  • Evaluation of biomaterial-based delivery systems for in situ cell transplantation.

Main Results:

  • Cell treatments show promise for functional recovery after SCI.
  • Combinatorial strategies enhance the efficacy of cell therapies.
  • Biomaterials offer novel in situ delivery methods for regenerative cells.

Conclusions:

  • Regenerative cell treatments, especially combinatorial strategies, hold significant therapeutic potential for SCI.
  • Biomaterial-based delivery systems are crucial for effective in situ cell therapy.
  • Multitargeted approaches are key to maximizing functional recovery in SCI patients.